GleamWall
中文EN

GPLB Green Planet Bio Engineering Co. Ltd.

Biological Products, (No Diagnostic Substances) · OTC · SEC CIK 1392449 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY—
TTM net income YoY-28.6%
TTM EPS YoY—
Revenue 3-yr CAGR—
Net income 3-yr CAGR—

Margins

Gross margin—
Operating margin—
Net margin—
FCF margin—
EBITDA margin—

Returns

ROE—
ROA—
ROIC (approx.)—
Asset turnover—

Leverage & solvency

Liabilities / assets—
Debt / equity—
Current ratio0.00x
Interest coverage—

Cash quality & payout

Operating cash flow / net income1.32x
Accruals ratio—
Payout ratio—
Capex / revenue—

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31
Income statement
Revenue——
SG&A expense$35,842$35,544
Interest expense$0$0
Pretax income-$35,842-$35,544
Income tax$0$0
Net income-$35,842-$35,544
EPS (diluted)0.000.00
Weighted avg. shares (diluted)20.01M20.01M
Balance sheet
Cash & equivalents$0$0
Current assets$0$0
Total assets——
Current liabilities$500,976$465,134
Total liabilities$500,976$465,134
Shareholders' equity-$500,976-$465,134
Shares outstanding20.01M20.01M
Cash flow statement
Operating cash flow-$36,544-$35,044
Investing cash flow—$35,044
Financing cash flow$36,544$35,044

Free plan shows the latest 2 periods; Pro shows all 16 🔒

· This company does not report gross profit in XBRL.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.